Biological Computing Market Report 2026

The biological computing market size has grown exponentially in recent years. It will grow from $2.21 billion in 2025 to $2.9 billion in 2026 at a compound annual growth rate (CAGR) of 31.2%. The growth in the historic period can be attributed to advancements in dna sequencing technologies, growth in genomics research funding, development of synthetic biology techniques, increasing demand for high performance computing alternatives, expansion of bioinformatics research ecosystems.

The biological computing market size is expected to see exponential growth in the next few years. It will grow to $8.64 billion by 2030 at a compound annual growth rate (CAGR) of 31.4%. The growth in the forecast period can be attributed to rising demand for ultra energy efficient computing systems, increasing adoption of personalized medicine applications, breakthroughs in dna data storage technologies, expansion of hybrid biological-digital computing models, growing investments in biotech computing startups. Major trends in the forecast period include dna-based computational architecture scaling, synthetic biology driven computing systems, bio-integrated hybrid computing platforms, molecular data storage and retrieval systems, laboratory automation for biocomputing workflows.

The increasing adoption of synthetic biology technologies is anticipated to drive the growth of the biological computing market in the coming years. Synthetic biology technologies refer to a range of engineering and biotechnology tools and methods used to design or construct biological systems for creating or modifying genetic code. The rise in synthetic biology technologies is driven by advancements in genetic engineering and biotechnology aimed at designing and modifying living organisms for useful medical applications. Biological computing supports synthetic biology technologies by enabling living cells to be engineered to process information and perform logical operations, allowing precise control of biological functions. For example, GenBank, a US-based public genetic sequence repository maintained by the National Centre for Biotechnology Information, reported that the database contained approximately 25 trillion base pairs and about 3.7 billion sequences in 2024, compared with around 34 trillion base pairs and 4.7 billion sequences in 2025, reflecting substantial year-over-year growth in global genomic data accumulation and sequencing output. Therefore, the increasing adoption of synthetic biology technologies is driving the growth of the biological computing market.

Key companies operating in the biological computing market are increasingly focusing on developing innovative solutions, such as biocomputing online research platforms, to enable remote experimentation on living neural systems, accelerate brain-inspired computing research, and enhance the development of energy-efficient, adaptive computing technologies. Biocomputing online research platforms are cloud-based systems that allow researchers to remotely access and experiment on biological components, such as living neurons, to study and develop brain-inspired computing technologies. For example, in May 2024, FinalSpark SA, a Switzerland-based biotechnology research company, launched the Neuroplatform, the first remote research platform for biocomputing using human brain organoids by enabling scientists to access living neuron-based systems over the cloud, apply real-time electrical stimulation and record electrophysiological responses through multi-electrode arrays for continuous experimentation in organoid-based neural computation. Additionally, it also provides researchers with a cloud-based interface for remote experiment control, real-time electrophysiological monitoring, and data acquisition from living neuronal networks, along with long-duration biological system maintenance, enabling continuous experimentation on human brain organoids under controlled laboratory conditions.

In November 2023, VERSES Technologies Inc., a Canada-based artificial intelligence firm focused on cognitive computing and adaptive intelligence systems, formed a beta partnership with Cortical Labs Pty Ltd to study and assess living neuronal networks. Through this collaboration, VERSES Technologies seeks to investigate and create innovative methods for biological computing by combining its artificial intelligence frameworks with living neural networks cultivated under laboratory conditions, enabling experimentation in hybrid intelligence systems that merge silicon-based computation with biological neurons. Cortical Labs Pty Ltd is an Australia-based neurotechnology company that specializes in biological computing systems using cultured neurons and hybrid neural-silicon platforms.

Major companies operating in the biological computing market are Thermo Fisher Scientific Inc., Illumina Inc., Ginkgo Bioworks Inc., Twist Bioscience Corporation, Oxford Nanopore Technologies plc, Synthego Corporation, Touchlight Genetics Ltd., Arzeda Corporation, Asimov Inc., LabGenius Ltd., ProteinQure Inc., Molecular Assemblies Inc., Catalog Technologies Inc., Iridia Inc., Helixworks Technologies Ltd., FinalSpark AG, Cortical Labs Pty Ltd., Biomemory SA, DNAli Data Technologies Inc., Atlas Data Storage Inc.

North America was the largest region in the biological computing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological computing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biological computing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biological computing market consists of revenues earned by entities by providing services such as bio-computational system design, synthetic biology-based computing solutions, biochip development, molecular data storage solutions, and system integration for hybrid biological-digital platforms. The market value includes the value of related goods sold by the service provider or included within the service offering. The biological computing market also includes sales of DNA synthesis tools, biochips, laboratory automation systems, microfluidic devices, sequencing platforms, and molecular computing kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.